Weaning vapotherm

OBJECTIVE: To evaluate the success rate of high-flow nasal cannula (HFNC) therapy using an adapted obsolete mechanical ventilator (MV), Optiflow™ and Vapotherm™ in newborns (NBs). METHOD: This was a retrospective observational study conducted in the neonatal intensive care unit (NICU). The sample comprised NBs who underwent HFNC therapy due to ventilatory dysfunction, for weaning from non-invasive ventilation (NIV), or post-extubation. The three groups, stratified according to gestational age (GA) and birth weight, and corrected GA and weight at the beginning of HFNC use, were as follows: Optiflow ™, Vapotherm ™, and obsolete Mechanical Ventilator (MV) adapted for high flow therapy...

BACKGROUND: Neonates often receive noninvasive respiratory support via continuous positive airway pressure (CPAP) or high-flow nasal cannula oxygen (HHFNC). The decision to change from one mode to the other, however, is not evidence based, hence not standardized and does not consider cost implications. PURPOSE: To assess the introduction of a care bundle for the medical and nursing staff in a tertiary medical and surgical neonatal center with regard to any financial savings or adverse outcomes...

INTRODUCTION: Current evidence supports nasal continuous positive airway pressure (NCPAP) weaning. Heated humidified high-flow nasal cannula (HHFNC) reduces NCPAP time in infants less than 28 weeks gestational age (GA) without increasing morbidity. The aim of the study was to compare the two most frequently used HHFNC devices in weaning from NCPAP. METHODOLOGY: We performed a retrospective matched-pair case-control study of infants less than or equal to 28 GA born in a single tertiary neonatal center managed with Optiflow or Vapotherm after being weaned from NCPAP...

SESSION TYPE: Miscellaneous Cases IIPRESENTED ON: Tuesday, October 23, 2012 at 11:15 AM - 12:30 PMINTRODUCTION: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Nonchemotherapeutic (bland) transarterial embolization (TAE) is one of the treatment options for unresectable HCC. We describe a case of hypoxemia after TAE likely due to embolization of microspheres to pulmonary circulation.CASE PRESENTATION: A 76 year old white male presented for bland TAE of HCC, measuring 7.7 x 6.9 cms...

AIM: Heated humidified high-flow nasal cannula (HHHFNC) oxygen is a relatively new form of respiratory support and is increasing in popularity despite lack of supportive evidence and amid safety concerns. We investigated the prevalence of its use in tertiary neonatal units in the UK. METHOD: Electronic survey. RESULTS: A total of 57 units were contacted and replies received from 44 (77%). HHHFNC was used in 34/44 (77%) units. Vapotherm 2000i and Fisher and Paykel RT329 were the most popular devices...

OBJECTIVE: To compare the effectiveness of Fisher and Paykel (FP) and Vapotherm (VT) high-flow nasal cannula (HFNC) in preventing reintubation either within 72 h or <7 days after extubation of premature infants. The primary outcome was the rate of extubation failure defined as reintubation within 72 h. Secondary outcomes included reintubation after ≤7 days. STUDY DESIGN: This was a prospective, randomized pilot study comparing the extubation success of 40 infants born between 26 and 29 weeks of gestation...

Neonatal units in the UK are beginning to use Vapotherm as a means of providing respiratory support. This device reportedly allows the delivery of high flows of gas at body temperature with close to 100 per cent relative humidity. Evidence from the literature and from UK neonatal units suggests that Vapotherm may be an effective and well-tolerated method of providing babies with respiratory support. It has a number of advantages over therapies such as nasal continuous positive airway pressure, including a reduction in the number of ventilator days and reduced nasal trauma...

OBJECTIVE: We compared two methods of delivering high-flow gas therapy by nasal cannula, applied immediately after planned endotracheal extubations of NICU patients. STUDY DESIGN AND METHODS: Thirty NICU patients who were about to be extubated from mechanical ventilation were randomized into two groups; Group 1 received Vapotherm for the first 24 h after extubation, then standard high-flow nasal cannula for the next 24 h, and Group 2 received standard high-flow therapy for the first 24 h, then Vapotherm for the next 24 h...